Susumu Shimoyama

2PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jan 03, 2025
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers.

Devalingam Mahalingam, Taofeek K Owonikoko, Ebrahim Delpassand

|Sep 08, 2023
FF-10850, a Novel Liposomal Topotecan Achieves Superior Antitumor Activity via Macrophage- and Ammonia-Mediated Payload Release in the Tumor Microenvironment.

Susumu Shimoyama, Ken Okada, Toshifumi Kimura

Pageof 1

Frequent Collaborators

1 joint publications

Ken Okada

1 joint publications

Toshifumi Kimura

1 joint publications

Yasushi Morohashi

1 joint publications

Shinji Nakayama

1 joint publications

Sayaka Kemmochi

1 joint publications

Keiko Makita-Suzuki

1 joint publications

Ursula A Matulonis

1 joint publications

Mikinaga Mori

1 joint publications

Devalingam Mahalingam

1 joint publications

Taofeek K Owonikoko

Frequent Collaborators

1 joint publications

Ken Okada

1 joint publications

Toshifumi Kimura

1 joint publications

Yasushi Morohashi

1 joint publications

Shinji Nakayama

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

348
Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on : Nov 01, 2017

8.5K
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

348
Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on : Nov 01, 2017

8.5K
See more related videos